New Key Statistics Module, Z-Score and F-Score
XSAT:NOHARM Key Ratios
| Market Cap kr M | 18.63 |
| Enterprise Value kr M | 35.99 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.46 |
| Price/Sales | 0.10 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 147.00 |
| EPS (TTM) kr | -0.15 |
| Beneish M-Score | -1.6 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -560.00 |
| EV-to-EBIT | -0.91 |
| EV-to-EBITDA | -1.68 |
| PEG | -- |
| Shares Outstanding M | 413.96 |
| Net Margin (%) | -30.98 |
| Operating Margin % | -29.41 |
| Pre-tax Margin (%) | -30.97 |
| Quick Ratio | 0.83 |
| Current Ratio | 1.35 |
| ROA % (ttm) | -32.37 |
| ROE % (ttm) | -102.21 |
| ROIC % (ttm) | -43.92 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.04 |
XSAT:NOHARM Number of Guru Trades
XSAT:NOHARM Volume of Guru Trades
Gurus Latest Trades with XSAT:NOHARM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XSAT:NOHARM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers